drugset / Trial / NCT00405080
A Study in Healthy Subjects to Assess How Dosing of Rifampin Affects What the Body Does to a Dose of GW679769 (Casopitant).
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study will examine what the body does while taking GW679769 alone and together with rifampin in healthy adult subjects.
Timeline
- Start
- 2006-11-11
- Primary completion
- 2007-01-05
- Completion
- 2007-01-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Casopitant | Small molecule | 150 mg | Oral |
| Subject | Rifampin | Small molecule | 600 mg | Oral |